AE1/3

34βE12

CK5/6

CK7

CK8/18

CK20

CDX2

Adrenal cortical carcinoma

 −

0

0

 −

0

Bile duct, Cholangiocarcinoma

+

14

93

+

43

CEA+

Bladder, urothelial carcinoma

+

62

88

 +

29

CK17+

Breast carcinoma, ductal/lobular

+

−

96

+

0

GCDFP15+

Cervix, squamous cell carcinoma

 +

87

+

0

 CEA+

Colorectal adenocarcinoma

+

0

5

+

100

CEA+

Endometrial adenocarcinoma

+

50

100

 +

0

 CEA−

Gastric adenocarcinoma

 +

−

38

 +

50

CEA+

Hemangioendothelioma, epithelioid

+/−

−

−

−

CD31, CD34, F8 +

Liver, fibrolamellar hepatoma

−/+

−

+

+

−

Liver, hepatoma

−

14

−

+

−

 CEA−

Lung, adenocarcinoma

+

5

100

 +

10

TTF1+

Lung, small cell carcinoma,

+

−

43

+ 

0

TTF1+

Lung, squamous cell carcinoma

 +

 +

−

0

Merkel cell carcinoma

+

−

−

+ 

78

Mesothelioma

+

76

65

0

WT1+, Calrectinin+

Neuroendocrine tumor

 + 

10

56

 + 

6

Ovarian carcinoma, mucinous

+

−/+

100

+

+

Vim+

Ovarian carcinoma, non-mucinous

+

+/−

100

+

−

Vim+, WT1+,

Paget's disease, apocrine origin

+

Pancreatic adenocarcinoma

+

38

92

+

62

CEA+

Prostate adenocarcinoma

+

0

−/+

+ 

0

Renal, chromophobe RCC

+

0

+

0

CD117+, Vim−, RCC+

Renal, clear cell carcinoma

+

0

−

+

0

RCC+, Vim+, CD10+

Renal, Oncocytoma

+Scattered

0

CD117+

Renal, papillary RCC

 +

0

+

0

 RCC+, CD10+, Vim+/-

Salivary gland, all tumors

 +

93

100

+ 

0

Thymus, thymoma

 +

+/−

100

0

+

0

Thyroid, all tumors

 +

 +/−

−

98

+

+/−

TTF1+

Thyroid, papillary carcinoma

 +

+/−

−

₊

+

−

TTF1+, CK19+, Vim+